查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1912173

内毒素检测市场：市场洞察、竞争格局与预测（2033 年）

Endotoxin Testing Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 196 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球内毒素检测市场正经历显着成长，这主要得益于更严格的监管标准、技术进步以及製药、生物技术和医疗器材产业对产品安全性的日益重视。 2026 年，该市场规模为 15 亿美元，预计到 2033 年将达到 29 亿美元，预测期内复合年增长率 (CAGR) 将达到 10%。

市场概览

内毒素（脂多醣）是存在于革兰氏阴性菌外膜上的有害物质。注射剂、生物製品和医疗器材受到内毒素污染会导致严重的健康问题，包括发烧、感染性休克和发炎反应。 包括美国食品药物管理局 (FDA)、欧洲药品管理局 (EMA) 以及其他药品监管机构在内的全球监管机构，均要求对所有註射剂和生物製品进行严格的内毒素检测。

市场正在经历显着的创新，超越传统的检测方法，采用自动化、高通量和高灵敏度的内毒素检测技术。这种发展确保了更高的准确性、更快的检测结果以及对严格安全标准的遵守，为製造商和研究实验室提供了可靠的内毒素污染检测和管理解决方案。

主要市场驱动因子

推动内毒素检测市场成长的因素如下：

  • 1. 监管要求：全球监管机构强制要求对所有生物製品、注射剂和医疗器材进行全面的内毒素检测，从而产生了对检测解决方案的稳定需求。
  • 2.製药和生物技术领域的成长：随着疫苗、生物製品以及细胞和基因疗法的不断发展，精准的内毒素检测对于确保患者安全至关重要。 3. 技术进步：自动化、高通量检测方法的引入，例如显色法、浊度法和凝胶法，提高了检测的效率和可靠性。 4. 关注病人安全：人们对内毒素相关风险的认知不断提高，促使企业实施严格的检测方案和预防措施。 5. 新兴市场扩张：亚太和拉丁美洲地区製药和医疗器材製造的快速发展为市场参与者提供了巨大的成长机会。

商机

内毒素检测市场为企业和检测实验室提供了许多商机：

  • 自动化和高通量检测：自动化系统可减少人为误差，提高检测结果的重复性，并加快检测週期。
  • 外包和客製化服务：专业的内毒素检测服务供应商可提供经济高效的解决方案，尤其适合中小型製造商。
  • 拓展新兴市场：亚太和拉丁美洲地区医疗基础设施和药品生产的扩张为市场开闢了新的成长途径。
  • 创新产品：开发低内毒素回收率 (LER) 产品以及用于先进生物製剂和治疗性蛋白质的内毒素去除解决方案是关键的成长领域。

区域分析

  • 北美：北美市场占主导地位，这得益于其众多大型製药和生物技术公司、严格的监管以及先进的实验室基础设施。
  • 欧洲：欧洲市场预计将保持稳定成长，这得益于其强有力的监管、完善的研究机构以及自动化内毒素检测技术的日益普及。
  • 亚太地区：亚太地区预计将以最高的复合年增长率成长，这得益于其快速的工业化进程、不断扩大的製药生产以及不断增长的医疗保健投资。
  • 拉丁美洲：不断增长的药品产量和国际品质标准的采用正在推动市场成长。
  • 中东和非洲：医疗保健基础设施的不断改进以及病人安全意识的日益增强正在促进市场发展。

主要公司

全球内毒素检测市场竞争激烈，许多跨国公司和专业实验室提供种类繁多的产品和服务。主要市场参与者包括：

  • 赛默飞世尔科技 (Thermo Fisher Scientific)
  • 默克集团 (Merck KGaA，旗下品牌为 MilliporeSigma)
  • 查尔斯河实验室 (Charles River Laboratories)
  • 龙沙集团 (Lonza Group)
  • 生物梅里埃公司 (bioMerieux SA)
  • Toxin Technology, Inc.
  • Hycult Biotech
  • Associates of Cape Cod, Inc.
  • Sciex (丹纳赫集团)
  • 富士软片与光纯药美国公司 (FUJIFILM Wako Chemicals USA Corporation)
  • IDEXX Laboratories, Inc.
  • BioStress LLC
  • R&D Systems (Bio Techne Corporation)
  • CTS (Creative Bioarray/China)
  • Insight Genomics, Inc.

这些公司正致力于持续的产品创新、策略联盟、併购和地理扩张，以巩固其市场地位。

市场区隔

依检测方法：

  • 凝胶法内毒素检测
  • 显色法内毒素检测
  • 浊度法内毒素检测

依类型：

  • 内毒素检测产品
  • 鲎试剂
  • 支原体检测与清除
  • PCR支原体检测试剂盒
  • 支原体清除混合液
  • 客製化支原体侦测与清除服务
  • 配件
  • 设备
  • 内毒素清除产品
  • 低内毒素回收率 (LER) 产品
  • 脂多醣

按应用：

  • 医疗器材製造业
  • 药品製造
  • 包装製造
  • 原料生产

依地区划分：

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

目录

第一章 摘要整理

第二章：市场概览

  • 市场定义与细分
  • 市场动态
    • 驱动因素
    • 限制因素
    • 市场机遇
  • 价值链分析
  • 新冠疫情影响分析
  • 波特五力分析
  • 俄乌衝突的影响衝突
  • PESTLE 分析
  • 监理分析
  • 价格趋势分析
    • 当前价格及未来预测，2025-2033 年
    • 价格影响因素

第三章 全球内毒素检测市场预测，2020-2033 年

  • 全球内毒素检测市场预测，按检测方法划分，价值（十亿美元），2020-2033 年
    • 凝胶法内毒素检测
    • 显色法内毒素检测
    • 浊度法内毒素检测
  • 内毒素检测市场预测，按类型划分，价值（十亿美元），2020-2033 年
    • 内毒素检测产品
    • 鲎试剂 (LAL) 检测试剂
    • 支原体检测与移除
    • PCR 支原体检测试剂盒
    • 支原体去除混合液
    • 支原体客製化血浆检测与移除服务
    • 配件
    • 仪器
    • 内毒素去除产品
    • 低内毒素回收率 (LER) 产品
  • 内毒素检测市场按应用领域划分的预测，价值（十亿美元），2020-2033 年
    • 医疗器材製造
    • 製药製造
    • 包装製造
    • 原料生产
  • 全球内毒素检测市场按地区划分的预测，价值（十亿美元），2020-2033 年
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第四章：北美内毒素检测市场展望（2020-2033）

第五章：欧洲内毒素检测市场展望（2020-2033）

第六章：亚太地区内毒素检测市场展望（2020-2033）

第七章：拉丁美洲内毒素检测市场展望（2020-2033）

第八章：中东与非洲内毒素检测市场展望（2020-2033）

第9章 竞争情形

  • 企业对市场区隔热图
  • 企业市场占有率分析，2025年
  • 竞争仪表板
  • 企业简介
    • Thermo Fisher Scientific
    • Merck KGaA (MilliporeSigma)
    • Charles River Laboratories
    • Lonza Group
    • bioMerieux SA
    • Toxin Technology, Inc.
    • Hycult Biotech
    • Associates of Cape Cod, Inc.
    • Sciex (Danaher)
    • FUJIFILM Wako Chemicals USA Corporation

第十章附录

简介目录

The global endotoxin testing market is experiencing remarkable growth, driven by rising regulatory standards, technological advancements, and increased emphasis on product safety across pharmaceutical, biotechnology, and medical device industries. The market, valued at USD 1.5 billion in 2026, is projected to reach USD 2.9 billion by 2033, registering a robust CAGR of 10% during the forecast period.

Market Overview

Endotoxins, or lipopolysaccharides, are toxic substances present in the outer membrane of Gram-negative bacteria. Their contamination in injectable drugs, biologics, and medical devices can lead to severe health complications, including fever, septic shock, and inflammatory responses. This has prompted regulatory agencies worldwide, such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and various pharmacopeial authorities, to mandate rigorous endotoxin testing for all injectable and biologic products.

The market has witnessed significant innovation, moving beyond traditional testing methods to incorporate automated, high-throughput, and highly sensitive endotoxin detection technologies. This evolution ensures higher accuracy, faster results, and compliance with stringent safety standards, providing manufacturers and research organizations with reliable solutions to detect and control endotoxin contamination.

Key Market Drivers

Several factors are fueling the expansion of the endotoxin testing market:

  • 1. Regulatory Mandates: Global regulatory authorities require thorough endotoxin testing for all biologics, injectables, and medical devices, creating steady demand for testing solutions.
  • 2. Pharmaceutical and Biotech Growth: The increasing development of vaccines, biologics, and cell and gene therapies necessitates precise endotoxin detection to ensure patient safety.
  • 3. Technological Advancements: Adoption of automated, high-throughput methods such as chromogenic, turbidimetric, and gel clot assays enhances testing efficiency and reliability.
  • 4. Focus on Patient Safety: Growing awareness of endotoxin-related risks drives companies to adopt stringent testing protocols and preventive measures.
  • 5. Emerging Market Expansion: Rapid pharmaceutical and medical device manufacturing in Asia-Pacific and Latin America provides significant growth opportunities for market participants.

Business Opportunities

The endotoxin testing market offers multiple opportunities for companies and laboratories:

  • Automation and High-Throughput Testing: Automated systems reduce human error, improve reproducibility, and accelerate testing cycles.
  • Outsourced and Custom Services: Specialized endotoxin testing service providers offer cost-effective solutions, particularly for small and medium-sized manufacturers.
  • Emerging Market Penetration: Increasing healthcare infrastructure and pharmaceutical production in Asia-Pacific and Latin America open new avenues for growth.
  • Innovative Products: Development of low endotoxin recovery (LER) products and endotoxin removal solutions for advanced biologics and therapeutic proteins represents a significant growth segment.

Regional Analysis

  • North America: North America dominates the market due to the presence of leading pharmaceutical and biotechnology companies, stringent regulations, and advanced laboratory infrastructure.
  • Europe: Steady growth in Europe is driven by strong regulatory oversight, established research institutions, and growing adoption of automated endotoxin testing technologies.
  • Asia Pacific: The Asia-Pacific region is expected to grow at the highest CAGR, fueled by rapid industrialization, expansion of pharmaceutical manufacturing, and increasing healthcare investments.
  • Latin America: Market growth is supported by rising pharmaceutical production and adoption of international quality standards.
  • Middle East & Africa: Gradual improvements in healthcare infrastructure and growing awareness of patient safety contribute to market development.

Key Players

The global endotoxin testing market is highly competitive, with numerous multinational corporations and specialized laboratories offering a wide range of products and services. Leading market participants include:

  • Thermo Fisher Scientific
  • Merck KGaA (MilliporeSigma)
  • Charles River Laboratories
  • Lonza Group
  • bioMerieux SA
  • Toxin Technology, Inc.
  • Hycult Biotech
  • Associates of Cape Cod, Inc.
  • Sciex (Danaher)
  • FUJIFILM Wako Chemicals USA Corporation
  • IDEXX Laboratories, Inc.
  • BioStress LLC
  • R&D Systems (Bio Techne Corporation)
  • CTS (Creative Bioarray / China)
  • Insight Genomics, Inc.

These companies focus on continuous product innovation, strategic partnerships, mergers, and regional expansions to strengthen their market presence.

Market Segmentation

By Testing Methods:

  • Gel Clot Endotoxin Test
  • Chromogenic Endotoxin Test
  • Turbidimetric Endotoxin Test

By Type:

  • Endotoxin Detection Products
  • LAL Test Reagents
  • Mycoplasma Detection & Removal
  • PCR Mycoplasma Detection Kit
  • Mycoplasma Elimination Cocktail
  • Mycoplasma Detection and Elimination Custom Services
  • Accessories
  • Instrumentation
  • Endotoxin Removal Products
  • Low Endotoxin Recovery (LER) Products
  • Lipopolysaccharides

By Application:

  • Medical Device Manufacturing
  • Pharmaceutical Manufacturing
  • Packaging Manufacture
  • Raw Materials Production

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Endotoxin Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Endotoxin Testing Market Outlook, 2020 - 2033

  • 3.1. Global Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 3.1.1. Gel Clot Endotoxin Test
    • 3.1.2. Chromogenic Endotoxin Test
    • 3.1.3. Turbidimetric Endotoxin Test
  • 3.2. Global Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 3.2.1. Endotoxin Detection Products
    • 3.2.2. LAL Test Reagents
    • 3.2.3. Mycoplasma Detection & Removal
    • 3.2.4. PCR Mycoplasma Detection Kit
    • 3.2.5. Mycoplasma Elimination Cocktail
    • 3.2.6. Mycoplasma Detection and Elimination Custom Services
    • 3.2.7. Accessories
    • 3.2.8. Instrumentation
    • 3.2.9. Endotoxin Removal Products
    • 3.2.10. Low Endotoxin Recovery (LER) Products
  • 3.3. Global Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.3.1. Medical device manufacturing
    • 3.3.2. Pharmaceutical manufacturing
    • 3.3.3. Packaging manufacture
    • 3.3.4. Raw materials production
  • 3.4. Global Endotoxin Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Endotoxin Testing Market Outlook, 2020 - 2033

  • 4.1. North America Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 4.1.1. Gel Clot Endotoxin Test
    • 4.1.2. Chromogenic Endotoxin Test
    • 4.1.3. Turbidimetric Endotoxin Test
  • 4.2. North America Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 4.2.1. Endotoxin Detection Products
    • 4.2.2. LAL Test Reagents
    • 4.2.3. Mycoplasma Detection & Removal
    • 4.2.4. PCR Mycoplasma Detection Kit
    • 4.2.5. Mycoplasma Elimination Cocktail
    • 4.2.6. Mycoplasma Detection and Elimination Custom Services
    • 4.2.7. Accessories
    • 4.2.8. Instrumentation
    • 4.2.9. Endotoxin Removal Products
    • 4.2.10. Low Endotoxin Recovery (LER) Products
  • 4.3. North America Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.3.1. Medical device manufacturing
    • 4.3.2. Pharmaceutical manufacturing
    • 4.3.3. Packaging manufacture
    • 4.3.4. Raw materials production
  • 4.4. North America Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 4.4.2. U.S. Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 4.4.3. U.S. Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 4.4.4. Canada Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 4.4.5. Canada Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 4.4.6. Canada Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Endotoxin Testing Market Outlook, 2020 - 2033

  • 5.1. Europe Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 5.1.1. Gel Clot Endotoxin Test
    • 5.1.2. Chromogenic Endotoxin Test
    • 5.1.3. Turbidimetric Endotoxin Test
  • 5.2. Europe Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 5.2.1. Endotoxin Detection Products
    • 5.2.2. LAL Test Reagents
    • 5.2.3. Mycoplasma Detection & Removal
    • 5.2.4. PCR Mycoplasma Detection Kit
    • 5.2.5. Mycoplasma Elimination Cocktail
    • 5.2.6. Mycoplasma Detection and Elimination Custom Services
    • 5.2.7. Accessories
    • 5.2.8. Instrumentation
    • 5.2.9. Endotoxin Removal Products
    • 5.2.10. Low Endotoxin Recovery (LER) Products
  • 5.3. Europe Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.3.1. Medical device manufacturing
    • 5.3.2. Pharmaceutical manufacturing
    • 5.3.3. Packaging manufacture
    • 5.3.4. Raw materials production
  • 5.4. Europe Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.2. Germany Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.3. Germany Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.4. Italy Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.5. Italy Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.6. Italy Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.7. France Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.8. France Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.9. France Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.10. U.K. Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.11. U.K. Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.12. U.K. Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.13. Spain Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.14. Spain Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.15. Spain Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.16. Russia Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.17. Russia Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.18. Russia Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.19. Rest of Europe Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.20. Rest of Europe Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.21. Rest of Europe Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Endotoxin Testing Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 6.1.1. Gel Clot Endotoxin Test
    • 6.1.2. Chromogenic Endotoxin Test
    • 6.1.3. Turbidimetric Endotoxin Test
  • 6.2. Asia Pacific Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 6.2.1. Endotoxin Detection Products
    • 6.2.2. LAL Test Reagents
    • 6.2.3. Mycoplasma Detection & Removal
    • 6.2.4. PCR Mycoplasma Detection Kit
    • 6.2.5. Mycoplasma Elimination Cocktail
    • 6.2.6. Mycoplasma Detection and Elimination Custom Services
    • 6.2.7. Accessories
    • 6.2.8. Instrumentation
    • 6.2.9. Endotoxin Removal Products
    • 6.2.10. Low Endotoxin Recovery (LER) Products
  • 6.3. Asia Pacific Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.3.1. Medical device manufacturing
    • 6.3.2. Pharmaceutical manufacturing
    • 6.3.3. Packaging manufacture
    • 6.3.4. Raw materials production
  • 6.4. Asia Pacific Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.2. China Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.3. China Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.4. Japan Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.5. Japan Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.6. Japan Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.7. South Korea Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.8. South Korea Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.9. South Korea Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.10. India Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.11. India Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.12. India Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.13. Southeast Asia Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.14. Southeast Asia Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.15. Southeast Asia Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.16. Rest of SAO Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.17. Rest of SAO Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.18. Rest of SAO Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Endotoxin Testing Market Outlook, 2020 - 2033

  • 7.1. Latin America Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 7.1.1. Gel Clot Endotoxin Test
    • 7.1.2. Chromogenic Endotoxin Test
    • 7.1.3. Turbidimetric Endotoxin Test
  • 7.2. Latin America Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 7.2.1. Endotoxin Detection Products
    • 7.2.2. LAL Test Reagents
    • 7.2.3. Mycoplasma Detection & Removal
    • 7.2.4. PCR Mycoplasma Detection Kit
    • 7.2.5. Mycoplasma Elimination Cocktail
    • 7.2.6. Mycoplasma Detection and Elimination Custom Services
    • 7.2.7. Accessories
    • 7.2.8. Instrumentation
    • 7.2.9. Endotoxin Removal Products
    • 7.2.10. Low Endotoxin Recovery (LER) Products
  • 7.3. Latin America Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.3.1. Medical device manufacturing
    • 7.3.2. Pharmaceutical manufacturing
    • 7.3.3. Packaging manufacture
    • 7.3.4. Raw materials production
  • 7.4. Latin America Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 7.4.2. Brazil Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 7.4.3. Brazil Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 7.4.4. Mexico Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 7.4.5. Mexico Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 7.4.6. Mexico Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 7.4.7. Argentina Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 7.4.8. Argentina Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 7.4.9. Argentina Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 7.4.10. Rest of LATAM Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 7.4.11. Rest of LATAM Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 7.4.12. Rest of LATAM Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Endotoxin Testing Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 8.1.1. Gel Clot Endotoxin Test
    • 8.1.2. Chromogenic Endotoxin Test
    • 8.1.3. Turbidimetric Endotoxin Test
  • 8.2. Middle East & Africa Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 8.2.1. Endotoxin Detection Products
    • 8.2.2. LAL Test Reagents
    • 8.2.3. Mycoplasma Detection & Removal
    • 8.2.4. PCR Mycoplasma Detection Kit
    • 8.2.5. Mycoplasma Elimination Cocktail
    • 8.2.6. Mycoplasma Detection and Elimination Custom Services
    • 8.2.7. Accessories
    • 8.2.8. Instrumentation
    • 8.2.9. Endotoxin Removal Products
    • 8.2.10. Low Endotoxin Recovery (LER) Products
  • 8.3. Middle East & Africa Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.3.1. Medical device manufacturing
    • 8.3.2. Pharmaceutical manufacturing
    • 8.3.3. Packaging manufacture
    • 8.3.4. Raw materials production
  • 8.4. Middle East & Africa Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.2. GCC Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.3. GCC Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 8.4.4. South Africa Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.5. South Africa Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.6. South Africa Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 8.4.7. Egypt Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.8. Egypt Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.9. Egypt Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 8.4.10. Nigeria Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.11. Nigeria Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.12. Nigeria Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 8.4.13. Rest of Middle East Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.14. Rest of Middle East Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.15. Rest of Middle East Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Merck KGaA (MilliporeSigma)
    • 9.4.3. Charles River Laboratories
    • 9.4.4. Lonza Group
    • 9.4.5. bioMerieux SA
    • 9.4.6. Toxin Technology, Inc.
    • 9.4.7. Hycult Biotech
    • 9.4.8. Associates of Cape Cod, Inc.
    • 9.4.9. Sciex (Danaher)
    • 9.4.10. FUJIFILM Wako Chemicals USA Corporation

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations